Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.00
+0.04 (0.45%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.52 billion as of August 13, 2026. Its market cap has increased by 151.73% in one year.
Market Cap
1.52B
Enterprise Value
1.08B
1-Year Change
151.73%
Ranking
Category
Stock Price
$9.00
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.52B, a decrease of -0.70%. That is a compound annual growth rate of -0.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.52B | 81.54% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.59B |
| Avalyn Pharma | 1.57B |
| Bicara Therapeutics | 1.56B |
| Maze Therapeutics | 1.51B |
| Maravai LifeSciences Holdings | 1.51B |
| Tyra Biosciences | 1.50B |
| Innoviva | 1.50B |
| ArriVent BioPharma | 1.46B |